Helping You Build Wealth With Honest Research
Since 1996. Try Now

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

NEOGEN CHEMICALS 2022-23 Annual Report Analysis
Wed, 16 Aug

NEOGEN CHEMICALS has announced its results for the year ended March 2023. Let us have a look at the detailed performance review of the company during FY22-23.

NEOGEN CHEMICALS Income Statement Analysis

  • Operating income during the year rose 40.8% on a year-on-year (YoY) basis.
  • The company's operating profit increased by 28.8% YoY during the fiscal. Operating profit margins witnessed a fall and stood at 16.3% in FY23 as against 17.8% in FY22.
  • Depreciation charges increased by 38.6% and finance costs increased by 51.7% YoY, respectively.
  • Other income grew by 315.9% YoY.
  • Net profit for the year grew by 12.0% YoY.
  • Net profit margins during the year declined from 9.2% in FY22 to 7.3% in FY23.

NEOGEN CHEMICALS Income Statement 2022-23

No. of Mths Year Ending 12 Mar-22* 12 Mar-23* % Change
Net Sales Rs m 4,873 6,862 40.8%
Other income Rs m 11 45 315.9%
Total Revenues Rs m 4,883 6,906 41.4%
Gross profit Rs m 868 1,117 28.8%
Depreciation Rs m 117 162 38.6%
Interest Rs m 191 289 51.7%
Profit before tax Rs m 571 710 24.5%
Tax Rs m 124 211 69.3%
Profit after tax Rs m 446 500 12.0%
Gross profit margin % 17.8 16.3
Effective tax rate % 21.8 29.6
Net profit margin % 9.2 7.3
* Results Consolidated
Interim results exclude extraordinary / exceptional items
Source: Accord Fintech, Equitymaster



5 PM TODAY: Golden Buying Window to Ride India's Potentially Decade-Long $10 Trillion Bull Run...

NEOGEN CHEMICALS Balance Sheet Analysis

  • The company's current liabilities during FY23 stood at Rs 4 billion as compared to Rs 2 billion in FY22, thereby witnessing an increase of 87.7%.
  • Long-term debt stood at Rs 1 billion as compared to Rs 1 billion during FY22, a growth of 6.2%.
  • Current assets rose 33% and stood at Rs 7 billion, while fixed assets rose 30% and stood at Rs 4 billion in FY23.
  • Overall, the total assets and liabilities for FY23 stood at Rs 11 billion as against Rs 8 billion during FY22, thereby witnessing a growth of 32%.

NEOGEN CHEMICALS Balance Sheet as on March 2023

No. of Mths Year Ending 12 Mar-22* 12 Mar-23* % Change
Networth Rs m 4,392 4,825 9.9
 
Current Liabilities Rs m 2,183 4,097 87.7
Long-term Debt Rs m 1,215 1,291 6.2
Total Liabilities Rs m 7,994 10,538 31.8
 
Current assets Rs m 4,925 6,558 33.2
Fixed Assets Rs m 3,070 3,980 29.6
Total Assets Rs m 7,994 10,538 31.8
* Results Consolidated
Interim results exclude extraordinary / exceptional items
Source: Accord Fintech, Equitymaster



NEOGEN CHEMICALS Cash Flow Statement Analysis

  • NEOGEN CHEMICALS's cash flow from operating activities (CFO) during FY23 stood at Rs -304 million on a YoY basis.
  • Cash flow from investing activities (CFI) during FY23 stood at Rs -945 million on a YoY basis.
  • Cash flow from financial activities (CFF) during FY23 stood at Rs 1 billion on a YoY basis.
  • Overall, net cash flows for the company during FY23 stood at Rs -245 million from the Rs 440 million net cash flows seen during FY22.

NEOGEN CHEMICALS Cash Flow Statement 2022-23

Particulars No. of months 12 12 % Change
Year Ending Mar-22 Mar-23
Cash Flow from Operating Activities Rs m 14 -304 -
Cash Flow from Investing Activities Rs m -1,458 -945 -
Cash Flow from Financing Activities Rs m 1,884 1,003 -46.8%
Net Cash Flow Rs m 440 -245 -
* Results Consolidated
Interim results exclude extraordinary / exceptional items
Source: Accord Fintech, Equitymaster



Current Valuations for NEOGEN CHEMICALS

  • The trailing twelve-month earnings per share (EPS) of the company stands at Rs 20.0, an improvement from the EPS of Rs 17.9 recorded last year.
  • The price to earnings (P/E) ratio, at the current price of Rs 1,573.0, stands at 80.8 times its trailing twelve months earnings.
  • The price to book value (P/BV) ratio at current price levels stands at 8.1 times, while the price to sales ratio stands at 5.7 times.
  • The company's price to cash flow (P/CF) ratio stood at 55.0 times its end-of-year operating cash flow earnings.

Per Share Data/Valuations

No. of Mths Year Ending 12 Mar-22* 12 Mar-23*
Sales per share (Unadj.) Rs 195.4 275.1
TTM Earnings per share Rs 17.9 20.0
Diluted earnings per share Rs 17.9 20.0
Price to Cash Flow x 77.3 55.0
TTM P/E ratio x 97.7 80.8
Price / Book Value ratio x 7.7 7.5
Market Cap Rs m 34,010 36,408
Dividends per share (Unadj.) Rs 2.8 3.0
* Results Consolidated
Interim results exclude extraordinary / exceptional items
Source: Accord Fintech, Equitymaster



Ratio Analysis for NEOGEN CHEMICALS

  • Solvency Ratios
  • Current Ratio: The company's current ratio deteriorated and stood at 1.6x during FY23, from 2.3x during FY22. The current ratio measures the company's ability to pay short-term and long-term obligations.

    Interest Coverage Ratio: The company's interest coverage ratio deteriorated and stood at 3.5x during FY23, from 4.0x during FY22. The interest coverage ratio of a company states how easily a company can pay its interest expense on outstanding debt. A higher ratio is preferable.

  • Profitability Ratios
  • Return on Equity (ROE): The ROE for the company improved and stood at 10.4% during FY23, from 10.2% during FY23. The ROE measures the ability of a firm to generate profits from its shareholders capital in the company.

    Return on Capital Employed (ROCE): The ROCE for the company improved and stood at 16.3% during FY23, from 13.6% during FY22. The ROCE measures the ability of a firm to generate profits from its total capital (shareholder capital plus debt capital) employed in the company.

    Return on Assets (ROA): The ROA of the company declined and down at 7.5% during FY23, from 8.0% during FY22. The ROA measures how efficiently the company uses its assets to generate earnings.

Key Ratio Analysis

No. of Mths Year Ending 12 Mar-22* 12 Mar-23*
Current ratio x 2.3 1.6
Debtors’ Days Days 8 9
Interest coverage x 4.0 3.5
Debt to equity ratio x 0.3 0.3
Return on assets % 8.0 7.5
Return on equity % 10.2 10.4
Return on capital employed % 13.6 16.3
* Results Consolidated
Interim results exclude extraordinary / exceptional items
Source: Accord Fintech, Equitymaster



To see how NEOGEN CHEMICALS has performed over the last 5 years, please visit here.

NEOGEN CHEMICALS Share Price Performance

Over the last one year, NEOGEN CHEMICALS share price has moved up from Rs 1,462.0 to Rs 1,573.0, registering a gain of Rs 111.0 or around 7.6%.

Overall, the S&P BSE SENSEX is up 10.5% over the year.

(To know more, check out historical annual results for NEOGEN CHEMICALS and quarterly results for NEOGEN CHEMICALS)

Annual Report FAQs

What is the current share price of NEOGEN CHEMICALS?

NEOGEN CHEMICALS currently trades at Rs 1,530.7 per share. You can check out the latest share price performance of NEOGEN CHEMICALS here...

What was the revenue of NEOGEN CHEMICALS in FY23? How does it compare to earlier years?

The revenues of NEOGEN CHEMICALS stood at Rs 6,906 m in FY23, which was up 41.4% compared to Rs 4,883 m reported in FY22.

NEOGEN CHEMICALS' revenue has grown from Rs 2,231 m in FY19 to Rs 6,906 m in FY23.

Over the past 5 years, the revenue of NEOGEN CHEMICALS has grown at a CAGR of 32.6%.

What was the net profit of NEOGEN CHEMICALS in FY23? How does it compare to earlier years?

The net profit of NEOGEN CHEMICALS stood at Rs 500 m in FY23, which was up 12.0% compared to Rs 446 m reported in FY22.

This compares to a net profit of Rs 313 m in FY21 and a net profit of Rs 287 m in FY20.

Over the past 5 years, NEOGEN CHEMICALS net profit has grown at a CAGR of 24.3%.

What does the cash flow statement of NEOGEN CHEMICALS reveal?

The cash flow statement is the financial statement that presents the cash inflows and outflows of a company during a given period of time.

This statement is one of the most useful tools for judging a company's liquidity position. The ratios and parameters in this statement helps test a company's financial health.

The cash flow statement of NEOGEN CHEMICALS reveals:

  • Cash flow from operations decreased in FY23 and stood at Rs -304 m as compared to Rs 14 m in FY22.
  • Cash flow from investments increased in FY23 and stood at Rs -945 m as compared to Rs -1,458 m in FY22.
  • Cash flow from financial activity decreased in FY23 and stood at Rs 1,003 m as compared to Rs 1,884 m in FY22.

Here's the cash flow statement of NEOGEN CHEMICALS for the past 5 years.

(Rs m)FY19FY20FY21FY22FY23
From Operations-37-34583614-304
From Investments-201-286-1,346-1,458-945
From Financial Activity2406265071,8841,003
Net Cashflow2-5-3440-245

What does the Key Ratio analysis of NEOGEN CHEMICALS reveal?

Be it the company's profitability, operations effectiveness or utilization of funds, ratio analysis is an important tool which helps in making investment decisions.

The ratio/financial analysis of NEOGEN CHEMICALS reveals:

  • Operating profit margins witnessed a fall and stood at 16.3% in FY23 as against 17.8% in FY22.
  • Net profit margins declined from 9.2% in FY22 to 7.3% in FY23.
  • Debt to Equity ratio for FY23 stood at 0.3 as compared to 0.3 in FY22.

Here's the ratio/financial analysis of NEOGEN CHEMICALS for the past 5 years.

 FY19FY20FY21FY22FY23
Operating Profit Margin (%)19.622.023.817.816.3
Net Profit Margin (%)9.410.811.59.27.3
Debt to Equity Ratio (x)0.70.20.60.30.3

Equitymaster requests your view! Post a comment on "NEOGEN CHEMICALS 2022-23 Annual Report Analysis". Click here!